News

Eli Lilly's obesity pill led to more than 12% weight loss in closely watched late-stage trial, paving way for approval
Eli Lilly's pill, orforglipron, is one step closer to becoming the first new, needle-free alternative in the booming market ...
Fierce Biotech43m
Lilly preps oral GLP-1 for regulatory review after phase 3 shows 12% weight loss
As other pharmas drop next-gen obesity assets, Eli Lilly’s experimental oral GLP-1 has prompted weight loss up to an average ...
Lilly: Q2 Earnings Snapshot
Earnings, adjusted for one-time gains and costs, came to $6.31 per share. The results surpassed Wall Street expectations. The ...
These Stocks Are Moving the Most Today: Fortinet, AppLovin, Eli Lilly, Airbnb, Duolingo, and More
A slew or company results were causing big market moves ahead of the opening bell Thursday, and for many, earnings-beat ...
The Daily Reporter12h
Eli Lilly and Co. could get $100 million in state tax credits
Eli Lilly is eligible for 100M in tax credits to expand its Pleasant Prairie facility, adding 750 jobs and boosting Wisconsin ...
Eli Lilly Earnings, Fed Speakers, Bank of England Rate Decision: Still to Come This Week
Earnings season marches on, with Eli Lilly among the big names yet to report this week. President Trump has said he will name replacements this week for Federal Reserve governor Adriana Kugler and [Bu ...
+12 relevant news
Jim Cramer Shows Concerns That Eli Lilly “Might Be a Little Diluted”
Eli Lilly and Company (NYSE:LLY) is one of the stocks in Jim Cramer’s game plan for this week. Cramer highlighted that his ...
Hosted on MSN2h
Nasdaq, S&P 500 Futures Climb Despite Trump Tariff Rollout — Spotlight On Jobs Data, Eli Lilly, Warner Bros. Earnings
U.S. stock futures strengthened early Thursday, despite a tariff threat looming large. President Donald Trump confirmed by ...